Optimizing Treatment for Patients with Metastatic Pancreatic Cancer, DNA Repair Defects

Researchers found that patients with metastatic pancreatic cancer who had germline or somatic mutations in DNA repair genes had better clinical outcomes after platinum-based chemotherapy.

Source: CancerNetwork - May 24, 2020 Category: Cancer & Oncology Authors: Hannah Slater Source Type: news